Allena Pharmaceuticals (NASDAQ:ALNAQ – Get Rating) is set to announce its earnings results on Tuesday, November 8th.
Allena Pharmaceuticals Stock Performance
Shares of Allena Pharmaceuticals stock remained flat at $0.01 on Monday. The stock had a trading volume of 363,247 shares, compared to its average volume of 12,972,626. The company's 50-day moving average is $0.02. Allena Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $1.00.
Get
Allena Pharmaceuticals alerts:
About Allena Pharmaceuticals
(Get Rating)
Allena Pharmaceuticals, Inc, a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease.
Read More
- Get a free copy of the StockNews.com research report on Allena Pharmaceuticals (ALNAQ)
- Bulls Vs Bears: Mullen Automotive Short Interest Grows
- Palantir Falls Into The Hands Of Value Investors
- The Analysts Can't Keep Up with Arista Networks Stock
- 3 Reasons Amazon Will Deliver Better 2023 Returns
- A Turnaround is Brewing in Starbucks Stock
Receive News & Ratings for Allena Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allena Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Allena Pharmaceuticals (NASDAQ:ALNAQ – Get Rating) is set to announce its earnings results on Tuesday, November 8th.
Allena Pharmicals(纳斯达克股票代码:ALNAQ — 获取评级)定于11月8日星期二公布其财报。
Allena Pharmaceuticals Stock Performance
Shares of Allena Pharmaceuticals stock remained flat at $0.01 on Monday. The stock had a trading volume of 363,247 shares, compared to its average volume of 12,972,626. The company's 50-day moving average is $0.02. Allena Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $1.00.
周一,艾伦娜制药的股价持平至0.01美元。该股的交易量为363,247股,而平均交易量为12,972,626股。该公司的50天移动平均线为0.02美元。艾伦娜制药创下12个月低点0.01美元,12个月高点为1.00美元。
Get
Allena Pharmaceuticals
alerts:
About Allena Pharmaceuticals
Allena Pharmaceuticals, Inc, a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease.
Allena Pharmicals, Inc是一家生物制药公司,在美国发现、开发和商业化口服酶疗法,用于治疗患有罕见和严重代谢和肾脏疾病的患者。其主要候选产品是 ALLN-346,这是一种新型的尿酸盐降解酶,适用于晚期慢性肾脏病背景下的高尿酸血症和痛风患者。
Read More
- Get a free copy of the StockNews.com research report on Allena Pharmaceuticals (ALNAQ)
- Bulls Vs Bears: Mullen Automotive Short Interest Grows
- Palantir Falls Into The Hands Of Value Investors
- The Analysts Can't Keep Up with Arista Networks Stock
- 3 Reasons Amazon Will Deliver Better 2023 Returns
- A Turnaround is Brewing in Starbucks Stock
- 免费获取 StockNews.com 关于艾伦娜制药(ALNAQ)的研究报告的副本
- 牛市与熊市:马伦汽车空头利率增加
- Palantir 落入价值投资者手中
- 分析师跟不上 Arista Networks 股票的步伐
- 亚马逊将在 2023 年提供更好退货的 3 个理由
- 星巴克股票正在酝酿转机
Receive News & Ratings for Allena Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allena Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接收《艾伦娜制药日报》的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Allena Pharmicals及相关公司的最新新闻和分析师评级的简明每日摘要。